Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Taekwang Industrial Co., Ltd. (003240.KS)
Seoul, KR
Taekwang Industrial Co., Ltd. operates extensively, both within South Korea and internationally, focusing on the production of synthetic fibers, textiles, petrochemicals, and advanced materials. Their synthetic fiber offerings include acrylic fibers, nylon filaments, spandex, and low-melting-point fibers, in addition to various spun yarns such as ring, open-end, acrylic, and acrylic-blended varieties. The company also manufactures a wide array of petrochemical products, encompassing purified terephthalic acids, propylene, acrylonitrile, sodium cyanide, acetonitrile, ammonium sulfate, and hydrogen peroxide. Furthermore, they provide tricot and polyester fabrics within their textile segment, and produce advanced materials like carbon and aramid fibers. Founded in 1950, Taekwang Industrial Co., Ltd. is headquartered in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.92% | -8.96% | -23.59% | -13.14% | +22.00% | +28.50% | +14.88% | +43.39% | -17.10% | +3.65% | +141.85% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-13.9% Q1'26: +5.1% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-77.1% Q1'26: -62.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-3.3% Q1'26: -10.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-1.6% Q1'26: -2.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%-1.2% Q1'26: -1.5% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+32.2% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.67× ★ Q1'26: -0.41× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
3.11T
est: 3.22T (-3.4%)
|
2.92T
est: 3.13T (-6.9%)
|
1.74T
est: 2.78T (-37.3%)
|
2.59T
est: 2.85T (-8.9%)
|
2.12T
est: 3.22T (-34.0%)
|
1.83T
est: 3.13T (-41.7%)
|
2.78T
2.78T – 2.78T
-11.5% YoY
|
2.85T
2.85T – 2.85T
+2.6% YoY
|
| EBITDA |
503.50B
est: 258.47B (+94.8%)
|
180.47B
est: 251.80B (-28.3%)
|
214.15B
est: 222.96B (-3.9%)
|
411.90B
est: 228.66B (+80.1%)
|
321.41B
est: 180.51B (+78.1%)
|
3.42B
est: 175.86B (-98.1%)
|
155.71B
155.71B – 155.71B
-11.5% YoY
|
159.70B
159.70B – 159.70B
+2.6% YoY
|
| EBIT |
360.29B
est: 179.69B (+100.5%)
|
110.80B
est: 175.06B (-36.7%)
|
166.06B
est: 155.00B (+7.1%)
|
353.93B
est: 158.97B (+122.6%)
|
278.54B
est: 108.22B (+157.4%)
|
-28.65B
est: 105.43B (-127.2%)
|
93.35B
93.35B – 93.35B
-11.5% YoY
|
95.74B
95.74B – 95.74B
+2.6% YoY
|
| Net Income |
214.11B
est: 150.47B (+42.3%)
|
136.06B
est: 118.00B (+15.3%)
|
153.28B
est: 176.92B (-13.4%)
|
316.36B
est: 201.61B (+56.9%)
|
214.53B
est: 198.99B (+7.8%)
|
80.82B
est: 156.04B (-48.2%)
|
233.97B
233.97B – 233.97B
+49.9% YoY
|
266.62B
266.62B – 266.62B
+14.0% YoY
|
| SGA |
566.80B
est: 216.24B (+162.1%)
|
552.29B
est: 210.66B (+162.2%)
|
149.22B
est: 186.53B (-20.0%)
|
151.87B
est: 191.30B (-20.6%)
|
152.02B
est: 216.76B (-29.9%)
|
159.83B
est: 211.16B (-24.3%)
|
186.98B
186.98B – 186.98B
-11.5% YoY
|
191.76B
191.76B – 191.76B
+2.6% YoY
|
| EPS |
254,395.00
est: 178,788.00 (+42.3%)
|
161,658.00
est: 140,199.00 (+15.3%)
|
182,119.00
est: 210,214.00 (-13.4%)
|
375,893.00
est: 239,550.00 (+56.9%)
|
254,892.00
est: 178,788.00 (+42.6%)
|
58,440.00
est: 140,199.00 (-58.3%)
|
210,214.00
210,214.00 – 210,214.00
+49.9% YoY
|
239,550.00
239,550.00 – 239,550.00
+14.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Energy&Chemicals 117460.KS | 0.24% | 40.7K | 0.45% |
| 2 | Kodex 200 Mid-Small 226980.KS | 0.15% | 20.3K | 0.30% |
| 3 | Kodex 200 Intrinsic Value 223190.KS | 0.04% | 7.2K | 0.30% |
| 4 | Kodex KOSPI 226490.KS | 0.03% | 237.1K | 0.15% |
| 5 | Kodex Inno-Tech Active 364690.KS | 0.03% | 5.1K | 0.30% |
| 6 | Samsung KODEX 200 ETF 069500.KS | 0.02% | 3.85M | 0.15% |
| 7 | Kodex 200TR 278530.KS | 0.02% | 1.11M | 0.05% |
| 8 | Kodex Leverage 122630.KS | 0.01% | 568.0K | 0.64% |
| 9 | Schwab International Small-Cap Equity ETF SCHC | 0.00% | 258.3K | 0.06% |
| 10 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.00% | 5.1K | 0.42% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| An-sik Jeong | Executive Director | — | male |
| Jeong-gyo Lim | ESG Support Director | — | — |
| Tae-ho Yoo | Chief Executive Officer, President & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 003240.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
